Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)

Clinical trial NCT00746486 · TERMINATED

Trial details

NCT number: NCT00746486
Sponsor: Dr. Falk Pharma GmbH
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cirrhosis

Start date: 2009-02-01
Primary completion: 2019-10-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.